Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1

Intravenous magnetic nanoparticle cancer hyperthermia

Authors Huang HS, Hainfeld JF

Received 7 February 2013

Accepted for publication 22 March 2013

Published 17 July 2013 Volume 2013:8(1) Pages 2521—2532

DOI https://doi.org/10.2147/IJN.S43770

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3


Video abstract presented by HS Huang and JF Hainfeld.

Views: 2054

Hui S Huang, James F Hainfeld

Nanoprobes, Yaphank, NY, USA

Abstract: Magnetic nanoparticles heated by an alternating magnetic field could be used to treat cancers, either alone or in combination with radiotherapy or chemotherapy. However, direct intratumoral injections suffer from tumor incongruence and invasiveness, typically leaving undertreated regions, which lead to cancer regrowth. Intravenous injection more faithfully loads tumors, but, so far, it has been difficult achieving the necessary concentration in tumors before systemic toxicity occurs. Here, we describe use of a magnetic nanoparticle that, with a well-tolerated intravenous dose, achieved a tumor concentration of 1.9 mg Fe/g tumor in a subcutaneous squamous cell carcinoma mouse model, with a tumor to non-tumor ratio > 16. With an applied field of 38 kA/m at 980 kHz, tumors could be heated to 60°C in 2 minutes, durably ablating them with millimeter (mm) precision, leaving surrounding tissue intact.

Keywords: magnetic nanoparticles, hyperthermia, cancer, alternating magnetic field, intravenous delivery

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]